| Literature DB >> 34835931 |
Tak Hiong Wong1, Alexiaa Sim1, Stephen F Burns1.
Abstract
Dietary nitrate supplementation has shown promising ergogenic effects on endurance exercise. However, at present there is no systematic analysis evaluating the effects of acute or chronic nitrate supplementation on performance measures during high-intensity interval training (HIIT) and sprint interval training (SIT). The main aim of this systematic review and meta-analysis was to evaluate the evidence for supplementation of dietary beetroot-a common source of nitrate-to improve peak and mean power output during HIIT and SIT. A systematic literature search was carried out following PRISMA guidelines and the PICOS framework within the following databases: PubMed, ProQuest, ScienceDirect, and SPORTDiscus. Search terms used were: ((nitrate OR nitrite OR beetroot) AND (HIIT or high intensity or sprint interval or SIT) AND (performance)). A total of 17 studies were included and reviewed independently. Seven studies applied an acute supplementation strategy and ten studies applied chronic supplementation. The standardised mean difference for mean power output showed an overall trivial, non-significant effect in favour of placebo (Hedges' g = -0.05, 95% CI -0.32 to 0.21, Z = 0.39, p = 0.69). The standardised mean difference for peak power output showed a trivial, non-significant effect in favour of the beetroot juice intervention (Hedges' g = 0.08, 95% CI -0.14 to 0.30, Z = 0.72, p = 0.47). The present meta-analysis showed trivial statistical heterogeneity in power output, but the variation in the exercise protocols, nitrate dosage, type of beetroot products, supplementation strategy, and duration among studies restricted a firm conclusion of the effect of beetroot supplementation on HIIT performance. Our findings suggest that beetroot supplementation offers no significant improvement to peak or mean power output during HIIT or SIT. Future research could further examine the ergogenic potential by optimising the beetroot supplementation strategy in terms of dosage, timing, and type of beetroot product. The potential combined effect of other ingredients in the beetroot products should not be undermined. Finally, a chronic supplementation protocol with a higher beetroot dosage (>12.9 mmol/day for 6 days) is recommended for future HIIT and SIT study.Entities:
Keywords: beetroot; high-intensity interval training; nitrate; nitric oxide; nitrite; sprint interval training
Mesh:
Substances:
Year: 2021 PMID: 34835931 PMCID: PMC8618171 DOI: 10.3390/nu13113674
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Selection process based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flowchart.
Summary of the included studies assessing the effect of dietary beetroot supplementation on HIIT and SIT performance.
| Study | Year | Sample Size ( | Age (Years) | Exercise Level and Fitness, VO2peak/max (mL/kg/min) | A/C | Beetroot Juice Supplementation | Study Design | Exercise Protocol | Primary Outcome |
|---|---|---|---|---|---|---|---|---|---|
| Bernardi et al. [ | 2018 | 10 | 24.9 ± 4.6 | Well-trained competitive mixed martial arts athletes. | A | 9.3 mmol (400 mL) | Randomised, crossover, double blind | 20 all-out 6 s sprints, 24 s of recovery. | No significant improvement in peak and mean power. Peak power (BR: 10.54 ± 0.62 W/kg vs. PL: 10.52 ± 0.48 W/kg; |
| Ernest et al. [ | 2016 | 13 | 25.9 ± 7.5 | Competitively trained athletes. | A | 2 × 11.2 mmol (2 × 70 mL) | Randomised, repeated measures, crossover, double blind | Maximal inertial-load cycling trials 4 × (3–4 s, 5 min passive rest) followed by maximal isokinetic cycling (30 s). | Peak power increased with BR (Pre: 1160 ± 301 W, post: 1229 ± 317 W) compared to PL (pre: 1191 ± 298 W, post: 1213 ± 300 W). Change in peak power post BR = 6.0 ± 2.6% compared to PL = 2.0 ± 3.8% ( |
| Kent et al. [ | 2019 | 12 | 22.3 ± 2.6 | Team-sport athletes. VO2 peak = 53.1 ± 8.7 | A | 12.9 mmol (2 × 70 mL) | Repeated measures, counter-balanced, double blind | 4 sets of 9 × 4 s Repeat-Sprint Efforts, 16 s active recovery, and 6 s passive rest recovery per sprint. Sets were separated by 3 min of low-intensity cycling. | No significant difference in peak and mean power output. Peak power (BR: 1152 ± 194 W vs. PL: 1164 ± 139 W), mean power (BR: 779 ± 156 W vs. PL: 804 ± 122 W). |
| Kokkinoplitis et al. [ | 2014 | 7 | 25.2 ± 3.3 | Healthy men. Exercise level not specified. | A | 6.45 mmol (70 mL) | Randomised, crossover, double blind | Repeated high intensity sprints (5 × 6 s) on a non-motorised treadmill with 30 s of recovery. | No significant difference in mean peak power and strength. Mean peak power (BR: 4133.5 ± 674.4 W vs. PL: 3838.3 ± 603.1 W; |
| Martin et al. [ | 2014 | 16 | M22.3 ± 2.1, F20.7 ± 1.3 | Team-sport athletes. V02max = 57.4 ± 8.5(M); V02max = 47.2 ± 8.5(F) | A | 4.84 mmol (70 mL) | Randomised, crossover, double blind | 8 s sprints with 30 s recovery on a cycle ergometer to exhaustion. | No significant difference in mean power output and mean peak power. Mean power (BR: 447 ± |
| Muggeridge et al. [ | 2013 | 8 | 31.0 ± 15.0 | Trained. VO2peak = 49.0± 6.1 | A | 5 mmol (70 mL) | Randomised, crossover | 15 min steady-state paddling followed by five 10 s maximal effort SIT, 50 s active recovery. After 5 min rest, complete 1 km TT. | No difference in either peak power in the sprints or TT performance between conditions. Peak power (BR: 420 ± 23 W vs. PL: 404 ± 24 W; |
| Smith et al. [ | 2019 | 12 | 22.0 ± 4.0 | Recreationally trained. | A | 6.2 mmol (70 mL) | Randomised, counter- balanced, crossover, double blind | 20 maximal 6 s sprints, 114 s of active recovery. | No significant improvement in peak and mean power. Peak power (BR: 659 ± 100 W vs. PL: 693 ± 139 W; |
| Aucouturier et al. [ | 2015 | 12 | 22.8 ± 3.1 | Recreation team sport players. VO2peak = 46.6 ± 3.4 | C | 5.48 mmol/day for 3 days (500 mL) | Randomised, crossover, single blind | Cycle ergometer: number of sets until exhaustion (15 s at 170% maximal aerobic power, 30 s passive recovery periods). | Number of repetitions before exhaustion was significantly higher with BR compared PL (26.1 ± 10.7 vs. 21.8 ± 8.0, |
| Christensen et al. [ | 2013 | 10 | 29.0 ± 4.0 | Highly trained cyclists. VO2max = 72.1 ± 4.5 | C | 8.06 mmol/day for 6 days | Randomised, | VO2 kinetics (3 × 6 min at 298 ± 28 W), endurance (120 min preload followed by a 400 kcal time trial). Repeated sprint test (cycle ergometer): 6 × 20 s sprints, 100 s active recovery. | No significant difference in VO2 kinetics, exercise economy, time trial, peak, and mean power. Average peak power (BR: 746 ± 111 W vs. PL: 745 ± 121 W), mean power (BR: 630 ± 84 W vs. PL: 630 ± 92 W). |
| Jonvik et al. [ | 2018 | 52 | 27.0 ± 6.0 | Recreational cyclists ( | C | 12.9 mmol/day (140 mL) for 6 days | Randomised, crossover, double blind | 3 30 s Wingate tests (4 min active recovery). | No significant difference in peak and mean power output. Time to peak power improved by 2.8%. Peak power (BR: 1338 ± 30 W vs. PL: 1333 ± 30 W; |
| Nyakayiru et al. [ | 2017 | 32 | 23.0 ± 1.0 | Trained soccer players | C | 12.9 mmol/day (2 × 70 mL) for 6 days | Randomised, placebo-controlled, crossover, double blind | Yo-Yo IR1. | Performance (distance covered) improved by 3.4 ± 1.3%. Distance (BR: 1623 ± 48 m vs. PL: 1574 ± 47 m; |
| Pawlak-Chaouch et al. [ | 2019 | 9 | 21.7 ± 3.7 | Elite. VO2max > 65 | C | 5.2 mmol/day (500 mL) for 3 days | Randomised, placebo-controlled, crossover, single blind | SIE test until exhaustion. 15 s cycling at 170% of the maximal aerobic power, 30 s passive recovery. | No significant difference in mean power, total work completed and total repetitions. Mean power (BR: 579.2 ± 57.7 W vs. PL: 578.9 ± 54.3W). |
| Thompson et al. [ | 2016 | 36 | 24.0 ± 4.0 | Competitive team sport players | C | 6.4 mmol/day (70 mL) for 5 days | Randomised, crossover, double blind | Maximal 20 m sprints followed by the Yo-Yo IR1; 10 s active recovery, 5 min passive recovery. | 1.2% improvement in 20 m sprint; 3.9% improvement in distance covered. Distance (BR: 1422 ± 502 vs. PL: 1369 ± 505 m; |
| Thompson et al. [ | 2017 | 36 | M27.0 ± 8.0, F23.0 ± 4.0 | Recreationally active. VO2peak = 50.4 ± 11.4(M); VO2peak = 39.8 ± 5.8(F) | C | 13 mmol/day (2 × 70 mL) for 28 days | Randomised to matched independent groups, double blind | SIT with supplementation for 28 days or without training intervention. Two severe-intensity step tests, 3 min and 20 min passive recovery repeat until task failure. Training session, Wingate all out, 30 s (4 and 5 times), rest 4 min. | No performance improvement in TTE trial. Peak WR (BR: 321 ± 91 W vs. PL: 318 ± 73 W; |
| Thompson et al. [ | 2018 | 30 | M25.0 ± 6.0, F22.0 ± 3.0 | Recreationally active. VO2peak = 46.6 ± 7.5 (M). VO2peak = 39.9 ± 3.9 (F). | C | 12.8 mmol/day (2 × 70 mL) for 28 days | Randomised to matched independent groups, double blind | Two bouts of severe-intensity cycling, the first for 3 min and the second until task failure; 4-wk supervised SIT program (Wingate 30 s, 4 min rest). | No significant improvement in peak work rate. TTE increased in SIT BR (71%), SIT (47%) and SIT KNO3 (42%). |
| Wylie et al. [ | 2013 | 14 | 22.0 ± 2.0 | Recreational team-sport players. VO2max = 52 ± 7 | C | 7 × 70 mL (4.1 mmol). Around 29 mmol in 36 h | Randomised, crossover, double blind | Yo-Yo IR1. | Distance covered was 4.2% greater with BR compared to PL. Distance (BR: 1704 ± 304 m vs. PL: 1636 ± 288 m; |
| Wylie et al. [ | 2016 | 10 | 21.0 ± 1.0 | Team-sport players. VO2peak = 58 ± 8 | C | 8.2 mmol/day (2 × 70 mL) for 5 days. Test day 2 × 70 mL, and post-test 70 mL | Randomised, crossover, double blind | Twenty-four 6 s all-out sprints, 24 s of recovery; seven 30 s all-out sprints, 240 s of recovery, and six 60 s self-paced maximal efforts, 60 s of recovery; on days 3, 4, and 5 of supplementation, respectively. | Mean power output was significantly greater (5.4%) with BR relative to PL in the 24×6 s protocol only. 24 × 6 s protocol mean power (BR: 568 ± 136 W vs. PL: 539 ± 136 W; |
A: acute; C: chronic; s: seconds; min: minutes; SIE/SIT: sprint interval exercise; m: meter; M: males; F: females; TTE: time to exhaustion; W: Watt; WR: work rate; TT: Time trial; BR: beetroot; PL: placebo; KNO3: Potassium nitrate; Yo-Yo IR1: Yo-Yo Intermittent Recovery Test Level 1. All data are mean ± standard deviation.
Summary of supplementation strategy with sources of beetroot products.
| Study | Year | Exercise Level | A/C | Suppl. | Total NO3 Loaded (mmol) | Last Dose (h) | Source of Beetroot | % NOx Increase | Erg * |
|---|---|---|---|---|---|---|---|---|---|
| Bernardi et al. [ | 2018 | Trained | A | 9.3 mmol (400 mL) | 9.3 | 2 | Produced in house | No | |
| Ernest et al. [ | 2016 | Trained | A | 2 × 11.2 mmol (2 × 70 mL) | 22.4 | 2.5 | Beet it, James White Drinks Ltd., Ipswich, UK | Yes | |
| Kent et al. [ | 2019 | Trained | A | 12.9 mmol (2 × 70 mL) | 12.9 | 2 | Beet it, James White Drinks Ltd., Ipswich, UK | No | |
| Kokkinoplitisk et al. [ | 2014 | Recreationally active | A | 6.45 mmol (70 mL) | 6.45 | 3 | Beet It, James White Drinks Ltd., Ipswich, UK | No | |
| Martin et al. [ | 2014 | Trained | A | 4.84 mmol (70 mL) | 4.84 | 2 | Beet It, James White Drinks Ltd., Ipswich, UK | 1600% increase in | No |
| Muggeridge et al. [ | 2013 | Trained | A | 5 mmol (70 mL) | 5 | 3 | Beet IT organic shot, James White Drinks Ltd., Ipswich, UK | 360% increase in | No |
| Smith et al. [ | 2019 | Recreationally active | A | 6.2 mmol (70 mL) | 6.2 | 3 | Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK | No | |
| Aucouturier et al. [ | 2015 | Recreationally active | C | 5.48 mmol/day for 3 days (500 mL) | 16.44 | 3 | Pajottenlander TM, Belgium | 970% increase in | Yes |
| Christensen et al. [ | 2013 | Trained | C | 8.06 mmol/day for 6 days | 48.36 | 3 | Beet it, James White Drinks Ltd., Ipswich, UK | 298% increase in plasma NOx (nitrate + nitrite). | No |
| Jonvik et al. [ | 2018 | Recreationally trained and elite | C | 12.9 mmol/day (140 mL) for 6 days | 77.4 | 3 | Beet it, James White Drinks Ltd., Ipswich, UK | 1600% increase in | No |
| Nyakayiru et al. [ | 2017 | Trained | C | 12.9 mmol/day (2 × 70 mL) for 6 days | 77.4 | 2.5 | Beet It, James White Drinks Ltd., Ipswich, UK | 1100% increase | Yes |
| Pawlak-Chaouch et al. [ | 2019 | Elite | C | 5.2 mmol/day (500 mL) for 3 days | 15.6 | 2 | Pajottenlander TM, Belgium. | 325% increase in NOx | No |
| Thompson et al. [ | 2016 | Trained | C | 6.4 mmol/day (70 mL) for 5 days | 32 | 2.5 | Beet it, James White Drinks Ltd., Ipswich, UK | 659% increase in | Yes |
| Thompson et al. [ | 2017 | Recreationally active | C | 13 mmol/day (2 × 70 mL) for 28 days | 364 | 2.5 | Beet It, James White Drinks Ltd., Ipswich, UK | 960–1050% increase in | No |
| Thompson et al. [ | 2018 | Recreationally active | C | 12.8 mmol/day (2 × 70 mL) for 28 days | 358.4 | 2.5 | Beet it, James White Drinks Ltd., Ipswich, UK | 559% increase in | No |
| Wylie et al. [ | 2013 | Recreationally active | C | 7 × 70 mL (4.1 mmol). Around 29 mmol in 36 h | 29 | 2.5 and 1.5 | Beet it, James White Drinks Ltd., Ipswich, UK | 2972% increase in | Yes |
| Wylie et al. [ | 2016 | Recreationally active | C | 8.2 mmol/day (2 × 70 mL) for 5 days. Test day 2 × 70 mL, and post-test 70 mL | 49.2 | 2.5 and post test | Beet It, James White Drinks Ltd., Ipswich, UK | 238% increase in | Yes |
A: acute; C: chronic; s: seconds; min: minutes; BR: beetroot; PL: placebo; Suppl.: Supplementation; Erg: Ergogenic; hrs: hours. * Statistically significant change in power output/performance.
Figure 2Percentage nitrite increase in response to (a) nitrate dosage per day (r = 0.655, p = 0.078, N = 8) and (b) total nitrate dosage per trial (r = 0.878, p = 0.004, N = 8).
Figure 3Forest plot comparing the effect of acute and chronic beetroot supplementation on mean power output.
Figure 4Forest plot comparing the effect of acute and chronic beetroot supplementation on peak power output.
Figure 5Forest plot comparing the effect of chronic beetroot supplementation on peak and mean power output.
Figure 6Forest plot comparing the effect of beetroot supplementation on the distance covered in Yo-Yo IR1 test.
Nutritional information panel for beetroot products and beetroot juice. The values are presented in g/100 mL or mg/100 mL.
| Product | Beet It Sport Nitrate 400 Shot a | Beet It Organic Beetroot Juice b | Pajottenlander Red Beetroot Juice c | Beetroot Juice |
|---|---|---|---|---|
| Energy | 88 kcal/373 kJ | 32 kcal/142 kJ | 43 kcal/181 KJ | 95 kcal/399 kJ 1 |
| Protein | 3.7 g | 0.8 g | 1.0 g | 0.7 g 1 |
| Total Fat | 0.0 g | 0.0 g | <0.5 g | 0.2 g 1 |
| Carbohydrate | 18.0 g | 7.6 g | 8.5 g | 22.6 g 1 |
| Total Sugars | 17.0 g | 6.8 g | 7.0 g | 12.1 g 1 |
| Sodium | 480 mg | 80 mg | 50 mg | 43.9 mg 2 |
| Nitrate | 571 mg (400 mg per 70 mL) | 80 mg | Not declared | 99.2 mg 1 |
| Ingredients | Concentrated beetroot juice (98%), lemon juice (2%); made from concentrates. | Organic redbeet juice (90%), organic apple juice (10%); not from concentrate. | 100% lactofermented red beetroot juice | Beetroot Juice |
Source: a https://www.jameswhite.co.uk/product/beet-it-sport-shot/, accessed on 1 September 2021; b https://www.jameswhite.co.uk/product/beet-it-tetra-pack-1l/, accessed on 1 September 2021; c https://www.pajottenlander.be/?en/products/vegetable%2Djuice/308/red%2Dbeetroot%2Djuice/, accessed on 1 September 2021; 1 Nutritional, Bioactive and Physicochemical Characteristics of Different Beetroot Formulations, Baião, D. et al., 2017 [67]; 2 Compositional characteristics of commercial beetroot products and beetroot juice prepared from seven beetroot varieties grown in Upper Austria, Wruss J. et al., 2015 [68].
PEDro scores for the 17 included studies.
| Study ID | P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | P11 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bernadi et al. 2018 [ | x | x | x | o | o | o | O | x | x | x | x | 6 |
| Ernest et al. 2016 [ | o | x | x | o | x | x | X | x | x | x | x | 9 |
| Kent et al. 2019 [ | o | o | x | x | x | o | O | x | x | x | x | 7 |
| Kokkinoplitis et al. 2014 [ | x | x | x | x | x | o | O | x | x | x | x | 8 |
| Martin et al. 2014 [ | o | x | x | x | x | o | O | o | x | x | x | 7 |
| Muggeridge et al. 2013 [ | o | x | x | x | o | x | O | x | x | x | x | 8 |
| Smith et al. 2019 [ | o | x | x | o | x | x | O | x | x | x | x | 8 |
| Aucouturier et al. 2015 [ | x | x | x | x | x | o | O | x | x | x | x | 8 |
| Christensen et al. 2013 [ | o | x | x | o | x | o | O | x | x | x | x | 7 |
| Jonvik et al. 2018 [ | o | x | x | x | x | o | O | x | x | x | x | 8 |
| Nyakayiru et al. 2017 [ | o | x | x | o | x | o | O | o | x | x | x | 6 |
| Pawlak-Chaouch et al. 2019 [ | o | x | x | o | x | o | O | x | x | x | x | 7 |
| Thompson et al. 2016 [ | o | x | x | x | x | o | O | x | x | x | x | 8 |
| Thompson et al. 2017 [ | o | o | x | x | x | o | O | x | x | x | x | 7 |
| Thompson et al. 2018 [ | o | o | x | x | x | o | O | x | x | x | x | 7 |
| Wylie et al. 2013 [ | o | x | x | x | x | o | O | x | x | x | x | 8 |
| Wylie et al. 2016 [ | o | x | x | o | x | o | O | x | x | x | x | 7 |
| Score for each point | 18% | 88% | 100% | 59% | 88% | 18% | 6% | 88% | 100% | 100% | 100% | 7.4 |
x: Criterion met; o: Criterion not met; P1: Eligibility criteria were specified; P2: Randomised allocation of subjects; P3: Allocation was concealed; P4: Groups were similar at baseline regarding most important indicators; P5: Blinding of subjects; P6: Blinding of therapists; P7: Blinding of assessors; P8: Measures of key outcome > 85% participants; P9: Subjects received the allocated treatment; P10: Between-group stats comparisons reported for at least one key outcome; P11: Study provides both point measures and measures of variability. Please note that criterion P1 does not contribute to the overall study score.
Studies examining the acute effect of beetroot supplementation on isolated 30 s sprints (Wingate tests).
| Study | Sample Size ( | Age (Years) | Dosage | Study Design | Exercise Protocol | Primary Outcome |
|---|---|---|---|---|---|---|
| Cuenca et al. 2018 [ | 15 | 22.4 ± 1.6 | 6.4 mmol (70 mL) | Randomised, placebo controlled, crossover, double-blind | A 30 s all-out Wingate test. Before and after the sprint exercise and at 30 s and 180 s post-exercise, three counter-movement jumps (CMJ) were performed. | Improved peak (3.9%) and mean (3.9%) power output. Reduced the time taken to reach Wpeak (17.9%) |
| Domínguez et al. 2017 [ | 15 | 21.46 ± 1.72 | 5.6 mmol (70 mL) | Randomised and double blind | A 30 s maximum intensity test on an inertial cycle ergometer. | No impact on the mean power. Peak power improved by 5.4%. Shorter time taken to attain peak power (−8.4%). |
| Jodra et al. 2020 [ | 15 | 23.0 ± 2.0 | 6.4 mmol (70 mL) | Randomised, crossover, double blind | A 30 s all-out Wingate cycling test. | Increased peak power output by 4.4%. Lower the time taken to reach peak (7.3 vs. 8.7 s). |